186 related articles for article (PubMed ID: 38144556)
81. Dangerous liaisons? The role of inflammation and comorbidities in HIV and SARS-CoV-2 infection.
Maggi P; Ricci E; Messina V; Salzillo A; Simeone F; Iodice A; Socio GV
Expert Rev Clin Immunol; 2021 Mar; 17(3):201-208. PubMed ID: 33538189
[TBL] [Abstract][Full Text] [Related]
82. A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis.
McLaughlin KM; Bojkova D; Kandler JD; Bechtel M; Reus P; Le T; Rothweiler F; Wagner JUG; Weigert A; Ciesek S; Wass MN; Michaelis M; Cinatl J
Curr Issues Mol Biol; 2021 Sep; 43(3):1212-1225. PubMed ID: 34698067
[TBL] [Abstract][Full Text] [Related]
83. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.
Xu B; Li G; Guo J; Ikezoe T; Kasirajan K; Zhao S; Dalman RL
J Vasc Surg; 2021 Nov; 74(5):1740-1751. PubMed ID: 33600934
[TBL] [Abstract][Full Text] [Related]
84. Metabolic risk factors and risk of Covid-19: A systematic review and meta-analysis.
Moazzami B; Chaichian S; Kasaeian A; Djalalinia S; Akhlaghdoust M; Eslami M; Broumand B
PLoS One; 2020; 15(12):e0243600. PubMed ID: 33320875
[TBL] [Abstract][Full Text] [Related]
85. Single-cell analysis of adult human heart across healthy and cardiovascular disease patients reveals the cellular landscape underlying SARS-CoV-2 invasion of myocardial tissue through ACE2.
Chen C; Wang J; Liu YM; Hu J
J Transl Med; 2023 May; 21(1):358. PubMed ID: 37259108
[TBL] [Abstract][Full Text] [Related]
86. Pulmonary Hypertensive Changes Secondary to COVID-19 Pneumonia in a Chronically SARS-CoV-2-Infected Bilateral Lung Explant.
Rohr JM; Strah H; Berkheim D; Siddique A; Radio SJ; Swanson BJ
Int J Surg Pathol; 2022 Jun; 30(4):443-447. PubMed ID: 34894817
[TBL] [Abstract][Full Text] [Related]
87. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
88. SARS-CoV-2 RT-PCR profile in 298 Indian COVID-19 patients: a retrospective observational study.
Bhattacharya B; Kumar R; Meena VP; Soneja M; Singh A; Das R; Xess A; Arif N; Vig S; Rastogi V; Tiwari P; Bhatnagar S; Mohan A; Wig N; Dar L
Pathog Dis; 2021 Jan; 79(1):. PubMed ID: 33053181
[TBL] [Abstract][Full Text] [Related]
89. Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.
Dubuc I; Prunier J; Lacasse É; Gravel A; Puhm F; Allaeys I; Archambault AS; Gudimard L; Villano R; Droit A; Flamand N; Boilard É; Flamand L
Front Immunol; 2022; 13():893792. PubMed ID: 35812400
[TBL] [Abstract][Full Text] [Related]
90. Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection.
Pei R; Feng J; Zhang Y; Sun H; Li L; Yang X; He J; Xiao S; Xiong J; Lin Y; Wen K; Zhou H; Chen J; Rong Z; Chen X
Protein Cell; 2021 Sep; 12(9):717-733. PubMed ID: 33314005
[TBL] [Abstract][Full Text] [Related]
91. SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice.
Dinnon KH; Leist SR; Okuda K; Dang H; Fritch EJ; Gully KL; De la Cruz G; Evangelista MD; Asakura T; Gilmore RC; Hawkins P; Nakano S; West A; Schäfer A; Gralinski LE; Everman JL; Sajuthi SP; Zweigart MR; Dong S; McBride J; Cooley MR; Hines JB; Love MK; Groshong SD; VanSchoiack A; Phelan SJ; Liang Y; Hether T; Leon M; Zumwalt RE; Barton LM; Duval EJ; Mukhopadhyay S; Stroberg E; Borczuk A; Thorne LB; Sakthivel MK; Lee YZ; Hagood JS; Mock JR; Seibold MA; O'Neal WK; Montgomery SA; Boucher RC; Baric RS
Sci Transl Med; 2022 Sep; 14(664):eabo5070. PubMed ID: 35857635
[TBL] [Abstract][Full Text] [Related]
92. [Predictors of thromboembolic complications in patients with severe SARS-CoV-2 coronavirus infection].
Podzolkov VI; Volchkova EV; Tarzimanova AI; Bragina AE; Ivannikov AA; Bykova EE; Shvedov II; Oganesyan KA; Isaeva AY
Ter Arkh; 2023 Dec; 95(11):907-912. PubMed ID: 38158944
[TBL] [Abstract][Full Text] [Related]
93. Incidence of New-onset Hypertension and New-onset Type 2 Diabetes during or after SARS-CoV-2 Infection.
Gupta A; Duggal R
J Assoc Physicians India; 2023 Oct; 71(10):78-82. PubMed ID: 38716528
[No Abstract] [Full Text] [Related]
94. The aging transcriptome and cellular landscape of the human lung in relation to SARS-CoV-2.
Chow RD; Majety M; Chen S
Nat Commun; 2021 Jan; 12(1):4. PubMed ID: 33397975
[TBL] [Abstract][Full Text] [Related]
95. SARS-CoV-2 infection aggravates chronic comorbidities of cardiovascular diseases and diabetes in mice.
Ma Y; Lu D; Bao L; Qu Y; Liu J; Qi X; Yu L; Zhang X; Qi F; Lv Q; Liu Y; Shi X; Sun C; Li J; Wang J; Han Y; Gao K; Dong W; Liu N; Gao S; Xue J; Wei Q; Pan S; Gao H; Zhang L; Qin C
Animal Model Exp Med; 2021 Mar; 4(1):2-15. PubMed ID: 33738432
[TBL] [Abstract][Full Text] [Related]
96. Endothelial Extracellular Vesicles Enriched in microRNA-34a Predict New-Onset Diabetes in Coronavirus Disease 2019 (COVID-19) Patients: Novel Insights for Long COVID Metabolic Sequelae.
Mone P; Jankauskas SS; Manzi MV; Gambardella J; Coppola A; Kansakar U; Izzo R; Fiorentino G; Lombardi A; Varzideh F; Sorriento D; Trimarco B; Santulli G
J Pharmacol Exp Ther; 2024 Mar; 389(1):34-39. PubMed ID: 38336381
[TBL] [Abstract][Full Text] [Related]
97. Single-Cell Expression Landscape of SARS-CoV-2 Receptor
Han G; Sinjab A; Hara K; Treekitkarnmongkol W; Brennan P; Chang K; Bogatenkova E; Sanchez-Espiridion B; Behrens C; Solis LM; Gao B; Girard L; Zhang J; Sepesi B; Cascone T; Byers LA; Gibbons DL; Chen J; Moghaddam SJ; Ostrin EJ; Scheet P; Fujimoto J; Shay J; Heymach JV; Minna JD; Dubinett S; Wistuba II; Stevenson CS; Spira AE; Wang L; Kadara H
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809063
[TBL] [Abstract][Full Text] [Related]
98. Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects.
Overed-Sayer C; Miranda E; Dunmore R; Liarte Marin E; Beloki L; Rassl D; Parfrey H; Carruthers A; Chahboub A; Koch S; Güler-Gane G; Kuziora M; Lewis A; Murray L; May R; Clarke D
Thorax; 2020 Sep; 75(9):754-763. PubMed ID: 32709610
[TBL] [Abstract][Full Text] [Related]
99. Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
Hostettler KE; Zhong J; Papakonstantinou E; Karakiulakis G; Tamm M; Seidel P; Sun Q; Mandal J; Lardinois D; Lambers C; Roth M
Respir Res; 2014 Dec; 15(1):157. PubMed ID: 25496490
[TBL] [Abstract][Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
